Furthermore, YKL-40 has been shown to stimulate the ERK1/2 pathway by activating CD138 receptors and αvβ3 integrin, promoting angiogenesis, proliferation, and invasion of cancer cells in cutaneous T-cell lymphoma [34]. This evidence concerns the gene CHI3L1 and cancer.